In a significant step forward for computer-aided discovery of biomolecules, NVIDIA has open-sourced its BioNeMo Framework, a comprehensive toolkit of programming resources, libraries, and AI models designed specifically for drug discovery. This move empowers academic labs and biotech companies with the tools necessary for protein design, small molecule generation, and custom model development. By leveraging GPU optimization, BioNeMo is poised to accelerate biochemical predictive modeling, paving the way for groundbreaking advancements in the field.
The BioNeMo ecosystem comprises a framework of programming tools and packages offering access to optimized, pre-trained biomolecular models and workflows, as well as easy-to-use inference microservices with built-in API endpoints. Notable companies such as Amgen, Cognizant, and Cadence have already harnessed the power of BioNeMo to enhance biologics discovery and development, accelerate drug discovery, and shorten time to trusted results in therapeutic design.
↧